The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must not distort NHS priorities or be a pilot for a new pricing system for all drugs.
The Ethical Medicines Industry Group (EMIG) has made the remarks in response to the government’s consultation on the Cancer Drugs Fund, the full version of which is set for launch in April this year.